Difference between revisions of "LncRNAWiki:G"
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !Name !Transcript ID !Alias !Description |- |''GABPB1-AS1'' |GABPB1-AS1 |N/A |GABPB1 antisense RNA 1 |-...") |
|||
(2 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
+ | <div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;"> | ||
+ | Jump to section in alphabetical order : [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] [[LncRNAWiki:C|'''C''']] [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] '''G''' [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] [[LncRNAWiki:Featured|'''BACK''']] | ||
+ | </div> | ||
+ | |||
{|class="wikitable sortable" style="width:90%;text-align:center" | {|class="wikitable sortable" style="width:90%;text-align:center" | ||
|- | |- | ||
Line 5: | Line 9: | ||
!Alias | !Alias | ||
!Description | !Description | ||
+ | !Disease | ||
|- | |- | ||
|''GABPB1-AS1'' | |''GABPB1-AS1'' | ||
Line 10: | Line 15: | ||
|N/A | |N/A | ||
|GABPB1 antisense RNA 1 | |GABPB1 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''GACAT1'' | |''GACAT1'' | ||
|[[ENST00000441383.1]] | |[[ENST00000441383.1]] | ||
− | |LINC00876, AC096655.1-002 | + | |"LINC00876, AC096655.1-002" |
|gastric cancer associated transcript 1 (non-protein coding) | |gastric cancer associated transcript 1 (non-protein coding) | ||
+ | |gastric cancer | ||
|- | |- | ||
|''GACAT2'' | |''GACAT2'' | ||
Line 20: | Line 27: | ||
|HMlincRNA717 | |HMlincRNA717 | ||
|gastric cancer associated transcript 2 (non-protein coding) | |gastric cancer associated transcript 2 (non-protein coding) | ||
+ | |gastric cancer | ||
|- | |- | ||
|''GACAT3'' | |''GACAT3'' | ||
Line 25: | Line 33: | ||
|lncRNA-AC130710 | |lncRNA-AC130710 | ||
|gastric cancer associated transcript 3 (non-protein coding) | |gastric cancer associated transcript 3 (non-protein coding) | ||
+ | |gastric cancer | ||
|- | |- | ||
|''GAPLINC'' | |''GAPLINC'' | ||
|[[GAPLINC]] | |[[GAPLINC]] | ||
|TCONSN/A00026238 | |TCONSN/A00026238 | ||
− | |gastric adenocarcinoma associated, positive CD44 regulator, long intergenic non-coding RNA | + | |"gastric adenocarcinoma associated, positive CD44 regulator, long intergenic non-coding RNA" |
+ | |gastric cancer | ||
|- | |- | ||
|''GAS1RR'' | |''GAS1RR'' | ||
Line 35: | Line 45: | ||
|LncRNA-Hh | |LncRNA-Hh | ||
|GAS1 adjacent regulatory RNA | |GAS1 adjacent regulatory RNA | ||
+ | |_ | ||
|- | |- | ||
|''GAS5'' | |''GAS5'' | ||
|[[NONHSAT007663]] | |[[NONHSAT007663]] | ||
− | |SNHG2, ENSG00000234741 | + | |"SNHG2, ENSG00000234741" |
− | | | + | |_ |
+ | |autoimmune disease, B-cell neoplasms, breast cancer, kidney cancer, lymphoma, prostate cancer, melanoma, systemic lupus erythaematosus | ||
|- | |- | ||
|''GAS6-AS1'' | |''GAS6-AS1'' | ||
Line 45: | Line 57: | ||
|N/A | |N/A | ||
|GAS6 antisense RNA 1 | |GAS6 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''GAS8-AS1'' | |''GAS8-AS1'' | ||
Line 50: | Line 63: | ||
|N/A | |N/A | ||
|GAS8 antisense RNA 1 | |GAS8 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''GATA3-AS1'' | |''GATA3-AS1'' | ||
Line 55: | Line 69: | ||
|N/A | |N/A | ||
|GATA3 antisense RNA 1 | |GATA3 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''GATA6-AS1'' | |''GATA6-AS1'' | ||
Line 60: | Line 75: | ||
|locus5689 | |locus5689 | ||
|GATA6 antisense RNA 1 (head to head) | |GATA6 antisense RNA 1 (head to head) | ||
+ | |_ | ||
|- | |- | ||
|''GDNF-AS1'' | |''GDNF-AS1'' | ||
Line 65: | Line 81: | ||
|GDNFOS | |GDNFOS | ||
|GDNF antisense RNA 1 (head to head) | |GDNF antisense RNA 1 (head to head) | ||
+ | |_ | ||
|- | |- | ||
|''GHET1'' | |''GHET1'' | ||
Line 70: | Line 87: | ||
|lncRNA-GHET1 | |lncRNA-GHET1 | ||
|gastric carcinoma proliferation enhancing transcript 1 | |gastric carcinoma proliferation enhancing transcript 1 | ||
+ | |gastric cancer | ||
|- | |- | ||
|''GHRLOS'' | |''GHRLOS'' | ||
|[[NONHSAT087920]] | |[[NONHSAT087920]] | ||
− | |NCRNA00068,GHRL-AS1 | + | |"NCRNA00068,GHRL-AS1" |
|ghrelin opposite strand/antisense RNA | |ghrelin opposite strand/antisense RNA | ||
+ | |obesity, diabetes and cancer | ||
|- | |- | ||
|''GLIDR'' | |''GLIDR'' | ||
|[[GLIDR]] | |[[GLIDR]] | ||
− | |MGC21881, TCONSN/A00015562 | + | |"MGC21881, TCONSN/A00015562" |
|glioblastoma down-regulated RNA | |glioblastoma down-regulated RNA | ||
+ | |glioblastoma | ||
|- | |- | ||
|''GLIS3-AS1'' | |''GLIS3-AS1'' | ||
Line 85: | Line 105: | ||
|MGC16153 | |MGC16153 | ||
|GLIS3 antisense RNA 1 | |GLIS3 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''GNAS-AS1'' | |''GNAS-AS1'' | ||
|[[lnc-CTSZ-5:1]] | |[[lnc-CTSZ-5:1]] | ||
− | |GNAS antisense, GNAS1AS, NCRNA00075, NESP-AS, NESPAS, non-protein coding RNA 75, SANG, ENSG00000235590 | + | |"GNAS antisense, GNAS1AS, NCRNA00075, NESP-AS, NESPAS, ""non-protein coding RNA 75"", SANG, ENSG00000235590" |
|neuroendocrine secretory protein (Nesp) antisense. | |neuroendocrine secretory protein (Nesp) antisense. | ||
+ | |pseudohypoparathyroidism type Ib | ||
|- | |- | ||
|''GNG12-AS1'' | |''GNG12-AS1'' | ||
Line 95: | Line 117: | ||
|N/A | |N/A | ||
|GNG12 antisense RNA 1 | |GNG12 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''GPR1-AS'' | |''GPR1-AS'' | ||
Line 100: | Line 123: | ||
|GPR1AS | |GPR1AS | ||
|GPR1 antisense RNA | |GPR1 antisense RNA | ||
+ | |_ | ||
|- | |- | ||
|''GTSCR1'' | |''GTSCR1'' | ||
|[[GTSCR1]] | |[[GTSCR1]] | ||
|N/A | |N/A | ||
− | |Gilles de la Tourette syndrome chromosome region, candidate 1 (non-protein coding) | + | |"Gilles de la Tourette syndrome chromosome region, candidate 1 (non-protein coding)" |
+ | |_ | ||
+ | |- | ||
+ | |''G2E3-AS1'' | ||
+ | |[[G2E3-AS1]] | ||
+ | |CAT1647 | ||
+ | |G2E3 antisense RNA 1 | ||
+ | |Bladder cancer | ||
+ | |- | ||
+ | |''GCASPC'' | ||
+ | |[[GCASPC]] | ||
+ | |TCONS_00011605, RP1-56L9.7-001, lnc-SOD2-1 | ||
+ | |gall bladder cancer associated suppressor of pyruvate carboxylase lncRNA | ||
+ | |gallbladder cancer | ||
+ | |- | ||
+ | |''GPRC5D-AS1'' | ||
+ | |[[GPRC5D-AS1]] | ||
+ | |RP11-392P7.6 | ||
+ | |GPRC5D and HEBP1 antisense RNA 1 | ||
+ | |Colorectal cancer | ||
+ | |- | ||
+ | |''GSEC'' | ||
+ | |[[GSEC]] | ||
+ | |ST3GAL4-AS1, DCPS-AS1, FLJ39051 | ||
+ | |G-quadruplex forming sequence containing lncRNA | ||
+ | |colon cancer | ||
+ | - | ||
+ | |''GABPB1-IT1'' | ||
+ | |[[GABPB1-IT1]] | ||
+ | |FLJ10038 | ||
+ | |GABPB1 intronic transcript | ||
+ | |_ | ||
|} | |} |
Latest revision as of 12:36, 29 June 2017
Name | Transcript ID | Alias | Description | Disease | |||||
---|---|---|---|---|---|---|---|---|---|
GABPB1-AS1 | GABPB1-AS1 | N/A | GABPB1 antisense RNA 1 | _ | |||||
GACAT1 | ENST00000441383.1 | "LINC00876, AC096655.1-002" | gastric cancer associated transcript 1 (non-protein coding) | gastric cancer | |||||
GACAT2 | ENST00000579368.1 | HMlincRNA717 | gastric cancer associated transcript 2 (non-protein coding) | gastric cancer | |||||
GACAT3 | ENST00000426539.1 | lncRNA-AC130710 | gastric cancer associated transcript 3 (non-protein coding) | gastric cancer | |||||
GAPLINC | GAPLINC | TCONSN/A00026238 | "gastric adenocarcinoma associated, positive CD44 regulator, long intergenic non-coding RNA" | gastric cancer | |||||
GAS1RR | GAS1RR | LncRNA-Hh | GAS1 adjacent regulatory RNA | _ | |||||
GAS5 | NONHSAT007663 | "SNHG2, ENSG00000234741" | _ | autoimmune disease, B-cell neoplasms, breast cancer, kidney cancer, lymphoma, prostate cancer, melanoma, systemic lupus erythaematosus | |||||
GAS6-AS1 | GAS6-AS1 | N/A | GAS6 antisense RNA 1 | _ | |||||
GAS8-AS1 | GAS8-AS1 | N/A | GAS8 antisense RNA 1 | _ | |||||
GATA3-AS1 | GATA3-AS1 | N/A | GATA3 antisense RNA 1 | _ | |||||
GATA6-AS1 | GATA6-AS1 | locus5689 | GATA6 antisense RNA 1 (head to head) | _ | |||||
GDNF-AS1 | GDNF-AS1 | GDNFOS | GDNF antisense RNA 1 (head to head) | _ | |||||
GHET1 | GHET1 | lncRNA-GHET1 | gastric carcinoma proliferation enhancing transcript 1 | gastric cancer | |||||
GHRLOS | NONHSAT087920 | "NCRNA00068,GHRL-AS1" | ghrelin opposite strand/antisense RNA | obesity, diabetes and cancer | |||||
GLIDR | GLIDR | "MGC21881, TCONSN/A00015562" | glioblastoma down-regulated RNA | glioblastoma | |||||
GLIS3-AS1 | GLIS3-AS1 | MGC16153 | GLIS3 antisense RNA 1 | _ | |||||
GNAS-AS1 | lnc-CTSZ-5:1 | "GNAS antisense, GNAS1AS, NCRNA00075, NESP-AS, NESPAS, ""non-protein coding RNA 75"", SANG, ENSG00000235590" | neuroendocrine secretory protein (Nesp) antisense. | pseudohypoparathyroidism type Ib | |||||
GNG12-AS1 | GNG12-AS1 | N/A | GNG12 antisense RNA 1 | _ | |||||
GPR1-AS | NONHSAT076558 | GPR1AS | GPR1 antisense RNA | _ | |||||
GTSCR1 | GTSCR1 | N/A | "Gilles de la Tourette syndrome chromosome region, candidate 1 (non-protein coding)" | _ | |||||
G2E3-AS1 | G2E3-AS1 | CAT1647 | G2E3 antisense RNA 1 | Bladder cancer | |||||
GCASPC | GCASPC | TCONS_00011605, RP1-56L9.7-001, lnc-SOD2-1 | gall bladder cancer associated suppressor of pyruvate carboxylase lncRNA | gallbladder cancer | |||||
GPRC5D-AS1 | GPRC5D-AS1 | RP11-392P7.6 | GPRC5D and HEBP1 antisense RNA 1 | Colorectal cancer | |||||
GSEC | GSEC | ST3GAL4-AS1, DCPS-AS1, FLJ39051 | G-quadruplex forming sequence containing lncRNA | colon cancer
- |
GABPB1-IT1 | GABPB1-IT1 | FLJ10038 | GABPB1 intronic transcript | _ |